Related Experiment Video
Updated: Jun 17, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Lipid-based nanotherapeutics for siRNA delivery.
A Schroeder1, C G Levins, C Cortez
1Department of Chemical Engineering and David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Journal of Internal Medicine
|January 12, 2010
Summary
Lipid-based delivery systems are crucial for RNA interference (RNAi) therapies. This review explores molecular and structural factors influencing liposomal siRNA delivery systems for enhanced clinical applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- RNA interference (RNAi) utilizes small interfering RNA (siRNA) for gene silencing.
- Clinical RNAi necessitates safe and effective delivery systems.
- Lipid-based systems, particularly liposomes, are promising for siRNA delivery.
Purpose of the Study:
- To review molecular and structural parameters of lipid-based siRNA delivery systems.
- To highlight challenges and strategies for effective siRNA delivery.
- To inform the development of advanced liposomal siRNA carriers.
Main Methods:
- Review of existing literature on lipid-based siRNA delivery systems.
- Analysis of self-assembly mechanisms of lipoplexes.
- Discussion of factors influencing cellular uptake and endosomal escape.
- Examination of strategies to optimize particle size and surface modification (e.g., PEGylation) for reduced RES uptake and prolonged circulation.
Main Results:
- Lipid-based carriers self-assemble with siRNA via electrostatic interactions.
- Particle size (<100 nm) influences tissue accumulation and RES avoidance.
- Surface modification with hydrophilic polymers like PEG can reduce RES uptake and increase circulation time.
- Endosomal escape is critical for effective siRNA delivery.
Conclusions:
- Optimizing molecular and structural parameters of lipid-based systems is key for effective siRNA delivery.
- Liposomal siRNA carriers require careful design to balance cellular uptake, endosomal escape, and in vivo circulation.
- Further development of these systems holds significant potential for clinical RNAi applications.
More Related Videos
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10:33Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...